PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2014
Total Assets: $162.8M
Liabilities Breakdown FY2014
Total Liabilities: $45.7M
Asset Breakdown
Total Assets: $162.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $38.5M | 23.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.2M | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $122.1M | 75.0% |
Liabilities Breakdown
Total Liabilities: $45.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $15.0M | 32.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $30.7M | 67.2% |